GW Pharma CEO on recent cannabis-derived drug
GW Pharmaceuticals CEO Justin Gover discusses how the company secured FDA approval for its cannabis-derived drug and what it says referring to the capacity forward for cannabis-derived treatment.
Barneys Recent York CEO Daniella Vitale on cannabis paraphernalia
Danielle Vitale, president and CEO of Barneys Recent York, joins “Utter on the Avenue” to keep in touch about the firm’s resolution to launch selling excessive-finish cannabis items in its…